Copeptin-Troponin Composite Model Calculator

Clinical calculation support · Verify results before clinical use

Dual-Biomarker Assessment

Enter admission copeptin and hs-cTnI values, then indicate the ECG category. All fields are required.

<10 / ≤27Study cutoffs
Published dual-marker pathway threshold: <10 pmol/L.
The cited study used hs-cTnI ≤27 ng/L, corresponding to the assay-specific 99th percentile in that study.
A low-risk ECG was part of the published single-sample pathway; biomarker values alone are insufficient.

Clinical context

Copeptin reflects endogenous stress and can complement cardiac troponin, a biomarker of myocardial injury. The cited study assessed a single-sample dual-marker strategy in patients presenting with suspected acute myocardial infarction (AMI), together with a low-risk ECG.

Criteria used in the cited study

ComponentStudy criterionImportant limitation
Copeptin<10 pmol/LAssay and clinical context matter.
hs-cTnI≤27 ng/LAssay-specific threshold used in the study; do not generalize to all hs-cTnI assays.
ECGLow-risk ECGRequires clinician interpretation; not assessed by this calculator.

Interpretation and limitations

  • This tool checks whether the entered values match the published pathway criteria; it does not calculate an individualized probability of AMI or a general cardiovascular risk score.
  • The cited study reported a negative predictive value of 97.4% for its dual-marker pathway in its study cohort. Predictive values depend on population and clinical setting.
  • The study found that adding copeptin did not improve rule-out safety compared with a very-low-threshold single hs-cTnI strategy. Follow current guidelines and local protocols for suspected ACS.
  • Do not use this tool to delay urgent evaluation when symptoms, ECG, haemodynamic status, or clinical suspicion indicate possible acute coronary syndrome.

References

Ricci F, Neumann JT, Rübsamen N, et al. High-sensitivity troponin I with or without ultra-sensitive copeptin for the instant rule-out of acute myocardial infarction. Front Cardiovasc Med. 2022;9:895421. DOI: 10.3389/fcvm.2022.895421. PMID: 36017085.
European Society of Cardiology. 2023 ESC Guidelines for the management of acute coronary syndromes. European Heart Journal. Guideline publication.
Clinical disclaimer: This calculator is an educational aid that checks criteria from one published study. It is not a validated standalone diagnostic or prognostic instrument, does not replace clinical judgement, ECG interpretation, assay-specific cutoffs, serial troponin testing, or current local guidelines, and must not be used as the sole basis for patient disposition or treatment.